title: Switching the targeting pathways of a therapeutic antibody by nanodesign.
authors.affiliation: Department of Biochemistry and Molecular Biology, Guggenheim 1311B, College of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.
authors.forename: Sanjib
authors.initials: S
authors.lastname: Bhattacharyya
authors.forename: Raman Deep
authors.initials: RD
authors.lastname: Singh
authors.forename: Richard
authors.initials: R
authors.lastname: Pagano
authors.forename: J David
authors.initials: JD
authors.lastname: Robertson
authors.forename: Resham
authors.initials: R
authors.lastname: Bhattacharya
authors.forename: Priyabrata
authors.initials: P
authors.lastname: Mukherjee
mesh_terms: D000911:Antibodies, Monoclonal / Q000737:chemistry / Q000378:metabolism / Q000493:pharmacokinetics*; D061067:Antibodies, Monoclonal, Humanized; D045744:Cell Line, Tumor; D000068818:Cetuximab; D015195:Drug Design; D006046:Gold / Q000737:chemistry / Q000378:metabolism / Q000493:pharmacokinetics*; D006801:Humans; D053768:Metal Nanoparticles / Q000737:chemistry*; D008954:Models, Biological; D058726:Nanoconjugates / Q000737:chemistry*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D058726:Nanoconjugates; D006046:Gold; D000068818:Cetuximab